文献速递生殖医学

患者与治疗参数对人胚胎形态动力学的影响

An investigation into the effect of potential confounding patient and treatment parameters on human embryo morphokinetics.
PubMed 文献 · Fertil Steril · 2021-01-15

单中心回顾性队列分析纳入2014年9月至2016年1月间接受治疗的患者639例、于EmbryoScope培养6天的胚胎2376枚,以原核消失为时间零点,用多元回归分析BMI、母亲年龄、不孕诊断、治疗类型及抑制方案对19项形态动力学参数的影响,发现胚胎受患者与治疗参数影响细微且关系复杂,而非系统性效应。

要点

  • 患者与治疗参数对胚胎形态动力学参数仅有细微影响,且呈复杂关系而非系统性效应
  • 评估胚胎形态动力学与着床能力时需考虑混杂因素
  • 形态动力学参数与胚胎活力的关联可能因胚胎来源而异

核心结论

  • 胚胎受患者和治疗参数影响细微,各形态动力学参数与特定患者及治疗因素之间呈复杂关系,而非系统性效应。
  • 评估胚胎着床能力时需考虑混杂因素;形态动力学参数虽与胚胎活力相关,但可能因胚胎来源不同而异。

研究设计与样本

  • 单中心回顾性队列分析,纳入2014年9月至2016年1月间接受治疗的患者639例。
  • 胚胎于EmbryoScope培养6天,共2376枚。
  • 采用多元回归分析BMI、母亲年龄、不孕诊断、治疗类型及抑制方案对19项形态动力学参数的影响,以原核消失为时间零点。

主要发现

  • 分析的形态动力学参数包括t2、t3、t4、t5、t6、t7、t8、t9、tM、tSB、tB及s2、s3、cc2、cc3、cc4、t9-tM、tM-tSB、tSB-tB等间隔指标。
  • 通过Beta系数量化显著效应,胚胎受患者与治疗参数影响细微,呈复杂关系而非系统性效应。

临床怎么用

  • 在评估胚胎形态动力学及着床能力时应纳入患者与治疗混杂因素,不宜仅凭形态动力学参数判断胚胎活力。
  • 解读形态动力学指标时需考虑胚胎来源差异。

局限性

  • 单中心回顾性设计。
  • 仅纳入EmbryoScope培养6天的胚胎。
  • 未设干预措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the effect of patient and treatment parameters on 19 embryo morphokinetic parameters using pronuclear fading as time zero. DESIGN: Single-site, retrospective cohort analysis. SETTING: Fertility treatment center. PATIENTS(S): Patients undergoing treatment between September 2014 and January 2016 (n = 639) whose embryos were cultured in the EmbryoScope for 6 days (n = 2,376). INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Multiple regression analysis of body mass index; maternal age; infertility diagnosis; treatment type; suppression protocol on time to each cellular division (tn): t2, t3, t4, t5, t6, t7, t8, t9, time to start of compaction (tM), start of blastulation (tSB), full blastocyst (tB); and interval measurements: s2, s3, cc2, cc3, cc4, t9-tM, tM-tSB, and tSB-tB. Beta coefficients were analyzed to quantify any significant effects. RESULT(S): Embryos appeared to be subtly affected by patient and treatment parameters, exhibiting complex relationships between various morphokinetic parameters and specific patient and treatment factors, rather than a systemic effect. CONCLUSION(S): These findings outline the need for the consideration of confounding factors when assessing an embryo's ability to achieve implantation. Although morphokinetic parameters have been related to embryo viability, it is likely that this will vary depending on the embryo's origin.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Barrie A, McDowell G, Troup S, et al. An investigation into the effect of potential confounding patient and treatment parameters on human embryo morphokinetics. Fertil Steril. 2021. PMID: 33461751. doi:10.1016/j.fertnstert.2020.10.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。